Emerald Health Therapeutics and Skye Bioscience Announce Intended Closing Date of Plan of Arrangement

Stock Information for SpeakEasy Cannabis Club Ltd.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About SpeakEasy Cannabis Club Ltd.

Skye Bioscience to Host Virtual KOL Event and Provide Perspectives on Upcoming CBeyond(TM) Phase 2a Topline Clinical Data Readout
Skye Bioscience to Participate in Upcoming Investment and Medical Conferences
Skye Bioscience Reports Second Quarter 2025 Financial Results and Business Update
Skye Bioscience to Announce Second Quarter 2025 Financial Results and Business Update on August 7, 2025
Skye Bioscience Shares Nimacimab "Anatomy of Progress" Video Series and Highlights Preclinical CB1 Antibody Data Presented at the American Diabetes Association's 85th Scientific Sessions
Skye Bioscience to Present Expanded Preclinical CB1 Antibody Data at the American Diabetes Association's 85th Scientific Sessions
Skye Bioscience to Participate in Upcoming Investment Conferences
Skye Bioscience Establishes Partnership with Arecor Therapeutics to Develop Enhanced Formulation of Obesity Candidate Nimacimab

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.